Literature DB >> 8358705

Leishmaniases of the New World: current concepts and implications for future research.

G Grimaldi1, R B Tesh.   

Abstract

Recent epidemiologic studies indicate that leishmaniasis in the Americas is far more abundant and of greater public health importance than was previously recognized. The disease in the New World is caused by a number of different parasite species that are capable of producing a wide variety of clinical manifestations. The outcome of leishmanial infection in humans is largely dependent on the immune responsiveness of the host and the virulence of the infecting parasite strain. This article reviews current concepts of the clinical forms, immunology, pathology, laboratory diagnosis, and treatment of the disease as well as aspects of its epidemiology and control. Recommendations for future research on the disease and its control are made.

Entities:  

Mesh:

Year:  1993        PMID: 8358705      PMCID: PMC358284          DOI: 10.1128/CMR.6.3.230

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  282 in total

1.  Characterization and classification of leishmanial parasites from humans, wild mammals, and sand flies in the Amazon region of Brazil.

Authors:  G Grimaldi; H Momen; R D Naiff; D McMahon-Pratt; T V Barrett
Journal:  Am J Trop Med Hyg       Date:  1991-06       Impact factor: 2.345

2.  [Detection of amastigotes in cutaneous and mucocutaneous leishmaniasis using the immunoperoxidase method, using polyclonal antibody: sensibility and specificity compared with conventional methods of diagnosis].

Authors:  G Salinas; L Valderrama; G Palma; G Montes; N G Saravia
Journal:  Mem Inst Oswaldo Cruz       Date:  1989 Jan-Mar       Impact factor: 2.743

3.  Sequence arrangement of the 16S and 26S rRNA genes in the pathogenic haemoflagellate Leishmania donovani.

Authors:  W Leon; D L Fouts; J Manning
Journal:  Nucleic Acids Res       Date:  1978-02       Impact factor: 16.971

4.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

Authors:  E M Carvalho; W D Johnson; E Barreto; P D Marsden; J L Costa; S Reed; H Rocha
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

5.  Haemoflagellates: commercially available liquid media for rapid cultivation.

Authors:  L D Hendricks; D E Wood; M E Hajduk
Journal:  Parasitology       Date:  1978-06       Impact factor: 3.234

6.  Leishmanicidal activity of amino acid and peptide esters.

Authors:  M Rabinovitch
Journal:  Parasitol Today       Date:  1989-09

7.  Dermal leishmaniasis in the Amazon region of Brazil: Leishmania (Viannaia) lainsoni sp.n., a new parasite from the State of Pará.

Authors:  F T Silveira; J J Shaw; R R Braga; E Ishikawa
Journal:  Mem Inst Oswaldo Cruz       Date:  1987 Apr-Jun       Impact factor: 2.743

8.  Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.

Authors:  T R Navin; B A Arana; F E Arana; J D Berman; J F Chajón
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

9.  Immunologic responsiveness in American cutaneous leishmaniasis lesions.

Authors:  C Pirmez; C Cooper; M Paes-Oliveira; A Schubach; V K Torigian; R L Modlin
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

10.  Genetic control of the immune response in mice to Leishmania mexicana surface protease.

Authors:  J A López; H A Reins; R J Etges; L L Button; W R McMaster; P Overath; J Klein
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

View more
  110 in total

1.  Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil.

Authors:  Elisa Cupolillo; Lúcia Regina Brahim; Cristiane B Toaldo; Manoel Paes de Oliveira-Neto; Maria Edileuza Felinto de Brito; Aloisio Falqueto; Maricleide de Farias Naiff; Gabriel Grimaldi
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Molecular biological identification of monoxenous trypanosomatids and Leishmania from antropophilic sand flies (Diptera: Psychodidae) in Southeast Brazil.

Authors:  Leonardo de Souza Rocha; Claudiney Biral dos Santos; Aloísio Falqueto; Gabriel Grimaldi; Elisa Cupolillo
Journal:  Parasitol Res       Date:  2010-05-25       Impact factor: 2.289

3.  Reactive oxygen species-mediated immunity against Leishmania mexicana and Serratia marcescens in the sand phlebotomine fly Lutzomyia longipalpis.

Authors:  Hector Diaz-Albiter; Mauricio R V Sant'Anna; Fernando A Genta; Rod J Dillon
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

4.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  Molecular characterization, expression, and in vivo analysis of LmexCht1: the chitinase of the human pathogen, Leishmania mexicana.

Authors:  Manju B Joshi; Matthew E Rogers; Alison M Shakarian; Mat Yamage; Saeed A Al-Harthi; Paul A Bates; Dennis M Dwyer
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

6.  Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Authors:  Rúbia S Costa; Lucas P Carvalho; Taís M Campos; Andréa S Magalhães; Sara T Passos; Albert Schriefer; Juliana A Silva; Ednaldo Lago; Camilla S Paixão; Paulo Machado; Phillip Scott; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

7.  Functional variations in MBL2 gene are associated with cutaneous leishmaniasis in the Amazonas state of Brazil.

Authors:  F J de Araujo; T G Mesquita; L D O da Silva; S A de Almeida; W de S Vital; A Chrusciak-Talhari; J A de O Guerra; S Talhari; R Ramasawmy
Journal:  Genes Immun       Date:  2015-03-12       Impact factor: 2.676

8.  A unique, highly conserved secretory invertase is differentially expressed by promastigote developmental forms of all species of the human pathogen, Leishmania.

Authors:  Todd A Lyda; Manju B Joshi; John F Andersen; Andrew Y Kelada; Joshua P Owings; Paul A Bates; Dennis M Dwyer
Journal:  Mol Cell Biochem       Date:  2015-03-13       Impact factor: 3.396

9.  Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.

Authors:  Augusto M Carvalho; Camila F Amorim; Juliana L S Barbosa; Alexsandro S Lago; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

10.  Epitope mapping of the HSP83.1 protein of Leishmania braziliensis discloses novel targets for immunodiagnosis of tegumentary and visceral clinical forms of leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Matheus de Souza Gomes; João Luís Reis-Cunha; Ronaldo Alves Pinto Nagem; Cláudia Martins Carneiro; Eduardo Antônio Ferraz Coelho; Lúcia Maria da Cunha Galvão; Ricardo Toshio Fujiwara; Daniella Castanheira Bartholomeu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.